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ess: z.mckeough@fhs.uSummary The aim of the study was to determine whether 16 sessions of exercise
training, completed twice weekly, alters exercise capacity, quadriceps muscle
metabolism, cross-sectional area (CSA) and strength in subjects with chronic
obstructive pulmonary disease (COPD). We studied (a) 10 COPD subjects (mean
age7SEM ¼ 7172 years; FEV1 ¼ 0.9970.1 L) before and after 16 sessions of exercise
training, and (b) 10 healthy subjects (age ¼ 6873 years). The COPD subjects
underwent an incremental peak exercise test using a cycle ergometer and a 6-min
walk test: both improved following exercise training (Po0:05). Magnetic resonance
spectroscopy measurements, in quadriceps muscle, of post-exercise phosphocrea-
tinine (PCr) recovery kinetics were used to assess mitochondrial function in vivo: in
the COPD subjects pre-training this was 1978% lower than in healthy subjects
(P ¼ 0:03), but a 38712% increase was seen in the COPD subjects following training
(P ¼ 0:003). Magnetic resonance imaging was used to assess quadriceps CSA: after
training in the COPD subjects this showed a 772% increase (P ¼ 0:03). Quadriceps
strength, measured by the best of five maximum voluntary contractions, also showed
a 32711% increase in the COPD subjects (P ¼ 0:007). Sixteen sessions of exerciseElsevier Ltd. All rights reserved.
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Z.J. McKeough et al.1818training, performed twice weekly, increased exercise capacity as well as quadriceps
mitochondrial capacity, CSA and strength in the subjects with COPD.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Skeletal muscle dysfunction has been proposed to be
a primary determinant of reduced exercise capacity
in subjects with chronic obstructive pulmonary
disease (COPD).1 A number of studies have shown a
reduction in muscle endurance,2–6 strength7–9 and
muscle atrophy3,10,11 in subjects with COPD.
The cause of skeletal muscle dysfunction and the
extent to which it occurs in all COPD subjects is
currently under debate. Physical inactivity and
consequent deconditioning may be an important
cause, and so exercise training may be an im-
portant preventive and therapeutic strategy. Phy-
siological benefits from moderate-to-high-intensity
exercise training, performed 3–5 times weekly for
8–12 weeks, have been shown in subjects with
moderate to severe COPD12–14 including an increase
in muscle oxidative enzymes.13 No studies were
identified that have examined both muscle meta-
bolism and exercise capacity following twice
weekly, supervised exercise training.
Phosphorus magnetic resonance spectroscopy
(31P-MRS) is a non-invasive method of assessing
skeletal muscle metabolism at rest, during exercise
and in recovery. One study15 has used 31P-MRS to
examine the effect of cycle training performed five
times weekly for 8 weeks on quadriceps muscle
metabolism in moderate COPD, reporting a longer
than normal half-time of post-exercise phospho-
creatine recovery (PCr t1/2) in the COPD subjects
prior to training, suggestive of a defect of muscle
oxidative capacity, which improved after training.
The primary aim of this study was to examine the
effect of 16 sessions of an endurance and strength
training program, performed twice weekly, on
exercise capacity, quadriceps mitochondrial capacity,
and quadriceps cross-sectional area (CSA) and
strength in subjects with COPD. The hypothesis was
that the exercise training would increase exercise
capacity as well as quadriceps mitochondrial capa-
city, CSA and strength in the subjects with COPD.Methods
Subjects
Ten subjects diagnosed with COPD (6 male, 4
female) were recruited from the pulmonaryrehabilitation program at Royal Prince Alfred
Hospital (RPAH), Australia. Subjects were included
if they had COPD Stage II and Stage III as
classified by the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) standards16 and
excluded if they had previously undergone
pulmonary rehabilitation, required oxygen
therapy, were still smoking or suffered from
claustrophobia.
Ten healthy, age-matched, control subjects
(5 male, 5 female) were recruited from the general
community. These subjects had no respiratory
history and were sedentary, assessed by the
physical activity questionnaire17 in which sedentary
physical activity level was defined as expending
o10% of daily energy expenditure in the perfor-
mance of moderate-to-high-intensity activities
(i.e. a resting metabolic equivalent level 44
METS).18
All subjects were questioned about their capacity
to enter a magnetic field. Standard magnetic
resonance exclusions applied.
Informed, written consent was obtained from all
subjects, and the study was approved by the Ethics
Review Committee (RPAH zone) of the Sydney South
West Area Health Service.
All COPD subjects had testing performed at
baseline and following 8 weeks exercise training.
All healthy subjects had testing performed at
baseline only.Muscle tests
Both magnetic resonance imaging (MRI) and 31P-
MRS were performed. The same protocol was used
on all subjects. This protocol has been previously
described by this group.19 Subjects lay prone on a
custom-built rig positioned inside a Philips 1.5 T
Gyroscan Intera magnet (Philips Medical Systems,
Best, The Netherlands). The right thigh was
strapped to the rig (Fig. 1) with the P-100 pulse-
receive coil (Philips Medical Systems, Best, The
Netherlands) positioned under the right quadriceps
muscle. The right knee was flexed to 301 with the
lower leg positioned on a force platform which
was equipped with an electronic load cell (PT-100
PT electronics, Auckland NZ) to evaluate force
production.
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Figure 1 Schematic of leg positioning on the rig. (A)
force platform, (B) lower leg, (C) straps, (D) thigh.
Exercise capacity and quadriceps metabolism in COPD 1819Magnetic resonance imaging
Images of the right quadriceps muscle were taken
to assess CSA. Two transverse stacks of T2 weighted
images (6mm thick–30mm gap) were collected.
The area of the quadriceps muscle group was
analysed manually using the Philips Easy Vision
software (Philips Medical Systems, Best, The
Netherlands). The CSA was taken as the maximal
uncorrected area from review of all the single
images from that subject.Magnetic resonance spectroscopy
An adiabatic pulse sequence was used to collect
eight unlocalised 31P spectra (TR ¼ 1500ms),
summed to assess resting metabolic state. Spectra
were Fourier transformed and analysed for [PCr],
adenosine triphosphate ([ATP]), adenosine dipho-
sphate [ADP], and inorganic phosphate ([Pi]) using
the Java-based magnetic resonance user interface
(jMRUI version 2.0, EU Project).20 The chemical
shift between [PCr] and [Pi] was used to measure
muscle acidity (pH).21
Each subject performed five maximum voluntary
contractions of the right quadriceps muscle with
15 s of rest between contractions, taking the
highest value as the maximum voluntary contrac-
tion (MVC). The exercise protocol consisted of
pushing against the force platform at 60% MVC for
3 s followed by 1 s relaxation. Visual force feedback
was provided using a custom-built display unit
combined with a light metronome to ensure correct
timing of contraction and relaxation. The exercise
cycle was repeated for 3min (45 cycles), after
which the subject was rested for 7min. Spectra
were collected every 4 s during exercise and
recovery, 150 in all (TR 4000ms), and analysed as
for the resting spectra. In the COPD subjects, the
same relative workload (i.e. 60% MVC) was used
post-training following re-measurement of the
MVC.
Muscle oxidative function was assessed from the
recovery kinetics of PCr, fitting a least-squares
monoexponential time-function to determine the
halftime (t1/2) and initial rate of PCr resynthesis.The initial rate is a measure of the absolute end-
exercise rate of oxidative ATP synthesis, and the
halftime is an inverse measure of mitochondrial
capacity (independent of the degree of PCr deple-
tion), i.e. the maximum rate of oxidative ATP
synthesis22 if appropriate allowance is made for pH
change during exercise. We exploited the invariant
near-linear relationship between PCr t1/2 and end-
exercise pH23,24 first to establish group differences
in mitochondrial function, and then to calculate for
each subject the ratio of the PCr t1/2 predicted
from the end-exercise pH to that observed; this is a
robust measure of the mitochondrial capacity in a
subject relative to that on average in the controls.Lung function tests
In the COPD subjects, measurements of spirometry
and lung volumes were performed (Sensormedics
Vmax 20 and Sensormedics V6200 Autobox Body
Plethysmograph respectively; Sensormedics Cor-
poration, CA) and compared to predicted normal
values for spirometry25 and for lung volumes.26 In
the healthy subjects, measurements of spirometry
were performed using a hot-wire anemometer
(Minato Autospiro AS-500; Minato Medical Science,
Osaka, Japan).Exercise tests
Exercise tests were only performed in the COPD
subjects. An incremental symptom-limited cycle
test was performed on an electrically braked
bicycle ergometer (Sensormedics 800 Computerised
Ergometer, Sensormedics Corporation, CA). Each
subject breathed through a calibrated mass flow
sensor with expired gas sampled on a breath-by-
breath basis (Vmax 29 Cardiopulmonary Exercise
Testing Instrument; Sensormedics Corporation,
California, USA) so that oxygen consumption VO2,
carbon dioxide production, minute ventilation (VE),
tidal volume and breathing frequency could be
determined. The peak VO2 and peak workload from
this test were compared to the predicted normal
values.27 Heart rate (HR) and percent oxygen
saturation were obtained with a finger probe
attached to a pulse oximeter (N200: Nellcor,
Hayward CA). Each subject scored their dyspnea
and rate of perceived exertion on a modified Borg
scale reading 0 (‘‘nothing at all’’) to 10 (‘‘max-
imal’’). Peak values were compared before and
after exercise training.
A 6min walk test was conducted in accordance
with a standardised protocol.28 All subjects com-
pleted two walks separated by 30min rest. Each
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Z.J. McKeough et al.1820subject was asked to walk as far as they could in
6min up and down a 12m track which was marked
out by tape. Standardised encouragement was
given throughout. The better 6min walk distance
(6MWD) was used in the data analysis.Table 1 Anthropometric and lung function data
in the healthy control subjects (n ¼ 10) and in the
COPD subjects (n ¼ 10) before and after exercise
training (ET)
Healthy COPDExercise training
Each session of exercise training consisted of
supervised leg cycling, walking, and leg strength
training performed twice per week for 8 weeks.
Sixteen sessions of exercise were required to be
completed prior to final testing. The intensity of
cycle exercise was set from the peak leg cycle
exercise test. The cycle training initially con-
sisted of a 5-min warm-up at 40% peak work,
5–10min exercise at 60% peak work and a 5-min
cool-down at 40% peak work. The intensity and
duration of cycling was progressed as able.
The intensity was increased up to 80% peak work-
load by week 8 and the duration was progressed to
20min by week 4 and to 30min by week 8. The
intensity of walking was set at 80% of the walking
speed calculated from the initial 6min walk test,
for 20min initially and progressed to 30min by
week 8.
Strength training for the quadriceps was per-
formed on a leg extension machine. Training
consisted of two sets of 8–10 repetitions at 70% of
the one repetition maximum (1RM). This was
progressed, if able, up to three sets of 10
repetitions by week 4 and up to three sets of 10
repetitions at 80% of 1RM by week 8.control
baseline
Pre-ET Post-ET
Age (yr) 6873 7172 7172
BMI (kg/m2) 2572 2671 2671
FEV1 (L) 2.470.2 0.9970.1
 1.170.1
% pred 10374 4275 4476
FVC (L) 3.070.3 2.370.2 2.370.1
% pred 9374 6775 6973
TLC (L) 6.370.5 6.570.5
% pred 12076 12175
FRC (L) 4.570.4 4.570.4
% pred 150714 150712
RV (L) 4.070.4 4.070.4
% pred 188716 189715
Data are mean7SEM. BMI: body mass index; FEV1: forced
expiratory volume in 1 s; FVC: forced vital capacity; TLC:
total lung capacity; FRC: forced residual capacity; RV:
residual volume.
Significantly different from healthy control group
(Po0:05).Statistical analysis
Statistical analysis used StatView (Version 4.57
1992–1996, Abacus Concepts Inc., Berkeley, Cali-
fornia) and StatsDirect (v. 2.4.1 http://www.
statsdirect.com/). All data are presented as
mean7standard error of the mean (SEM). Variables
were compared between groups using an unpaired
t-test and within the COPD subjects from pre- to
post-training using a paired t-test. Grouped linear
regression was used to assess the relationship of
PCr t1/2 to end-exercise pH, and simple linear
regression to back-predict PCr t1/2 using the pH-t1/2
relationship in controls. Linear regression was used
to assess the relationship between change in
exercise capacity and mitochondrial capacity in
the subjects with COPD. A P-value of o0.05 was
taken to be significant.Results
Mean anthropometric data and lung function results
are presented in Table 1. Lung function in the COPD
subjects was significantly reduced compared to the
healthy subjects. The mean time to complete 16
sessions of exercise training in the COPD subjects
was 9.770.5 weeks. By the end of the 16 sessions,
90% of subjects had achieved the required walking
protocol, 30% had achieved the required cycling
protocol (of the remainder: 40% of subjects were
cycling for 20min at 60% peak work and 30% were
cycling for 30min at 60% peak work), and all
subjects were performing strength training for 3
sets of 10 repetitions at 70–80% 1RM.
Results of quadriceps muscle testing are pre-
sented in Table 2. There was a significant increase
in the initial rate of PCr resynthesis from pre- to
post-training in the COPD subjects. As PCr deple-
tion was also significantly greater from pre- to post-
training, the PCr t1/2 did not differ. The relation-
ship between PCr t1/2 and end-exercise pH had a
statistically indistinguishable slope in all three
groups, with a significant vertical separation
between COPD subjects pre-training and controls,
and between COPD subjects pre- and post-training
(both Po0:01) (Fig. 2A). Thus for a given pH
change, PCr t1/2 was higher (i.e. mitochondrial
ARTICLE IN PRESS
Table 2 Results of quadriceps muscle testing in the healthy control subjects (n ¼ 10) and in the COPD subjects
(n ¼ 10) before and after exercise training (ET)
Healthy
control
baseline
COPD
Pre-ET Post-ET
mean difference (95% CI)
Resting
Quads CSA, cm2 4775 4672 4973y
3 (3 to 6)
Resting pH 7.0470.01 7.0470.01 7.0670.01
0.02 (0.004 to 0.05)
Resting [PCr], mM 3371 3471 3471
0.4 (4 to 5)
Exercise
MVC, kg 2572 2473 3073y
6 (2 to 9)
End-exercise [PCr] fall, mM 1172 1372 1671y
3 (0.9 to 5)
End-exercise pH change 0.2670.07 0.2470.05 0.4070.09
0.2 (0.4 to 0.01)
End-exercise ADP, mM 3373 3576 3576
1 (17 to 14)
Recovery
Initial [PCr] resynthesis rate, mM/min 1371 1271 1972y
6 (2 to 11)
PCr t1/2, s 3573 4574 3975
5 (15 to 4)
Predicted/observed PCr t1/2 1.0270.04
z 0.8370.07 1.0970.07y
0.2 (0.1 to 0.4)
The mean difference from pre to post-ET is included with the 95% confidence interval (CI).Data are given as mean7SEM.
MVC: maximum voluntary contraction; CSA: cross-sectional area; pH: pH ¼ log10[H+]; [PCr]: phosphocreatine concentration;
PCr t1/2: phosphocreatine recovery half-time.
ySignificantly different to pre-ET (Po0:05).
zClose to 1 by definition.
Significantly different from healthy control group (Po0:05).
Exercise capacity and quadriceps metabolism in COPD 1821function was poorer) in COPD subjects pre-training
than in controls, but this difference was eliminated
by training. The mitochondrial abnormality in
individual subjects can be quantified by the ratio
of the PCr t1/2 predicted from end-exercise pH to
that observed. As Table 2 shows, this is reduced by
1978% in COPD subjects pre-training compared to
controls (P ¼ 0:03), and a significant improvement
of 38712% occurred with exercise training in the
COPD subjects (P ¼ 0:007) (Fig. 2B). There was also
a significant increase in MVC and muscle CSA
following exercise training (Fig. 2C).
Both the 6MWD and the peak workload on the
cycle ergometer significantly increased in the COPD
subjects following exercise training (Table 3).
A correlation in peak workload with the ratio
of the PCr t1/2 predicted from end-exercise pH tothat observed (i.e. measure of mitochondrial
capacity) approached statistical significance (r ¼
0:6; P ¼ 0:07).Discussion
This study examined the effect of 16 sessions of
endurance and strength exercise training, per-
formed twice weekly, on exercise capacity as well
as quadriceps mitochondrial capacity, strength and
CSA in subjects with COPD. Muscle function in the
COPD subjects prior to training was also compared
to a group of healthy subjects matched for age and
physical activity. Prior to exercise training, the
COPD subjects had a lower mitochondrial capacity
compared to the healthy controls, despite no
ARTICLE IN PRESS
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Figure 2 Results of muscle testing. (A) The relationship between PCr t1/2 and end-exercise pH change in the subjects
with COPD pre-exercise training (pre ET) and post-exercise training (post ET), and in the healthy control subjects: key
to symbols is in the panel. Lines are fitted by grouped linear regression (see Methods): that for COPD pre-exercise
training is significantly vertically shifted (see Results). (B) The relative mitochondrial capacity (derived from data in
Fig. 2A: see Methods) in the subjects with COPD pre-exercise training (pre ET) and post-exercise training (post ET), and
in the healthy control subjects: key to symbols is in the panel. Lines join pre- and post-exercise training data. Pre-
exercise training mean in the subjects with COPD is significantly lower than control, and increases significantly pre-
to post-exercise training (see Table 2). (C) Quadriceps CSA in the subjects with COPD pre-exercise training (pre ET) and
post-exercise training (post ET), and in the healthy control subjects: key to symbols is in the panel. Lines join pre- and
post-exercise training data. There was a significant increase from pre- to post-exercise training in the COPD subjects
(see Table 2).
Z.J. McKeough et al.1822difference between groups in the size of the
muscle. Following exercise training in the COPD
subjects, exercise capacity as well as quadriceps
mitochondrial capacity, CSA and strength all sig-
nificantly increased.Comparison of muscle function in COPD and
health
As in other studies29–31 there were no significant
abnormalities in resting [PCr] or pH in the subjects
with COPD. Thus the metabolic impairment in the
COPD subjects was not sufficiently severe as to be
unequal to the metabolic demands of the resting
muscle. One way to further examine muscle
mitochondrial capacity is to exercise the musclesufficiently to cause [PCr] depletion and then
observe the recovery of [PCr] once exercise stops.32
There are several ways of doing this: the more
intense the exercise the greater the PCr depletion
achieved, and the better the precision of the
crucial measurement of PCr t1/2, but the associated
pH fall makes the interpretation more difficult, and
runs the risk of ATP depletion. Alternative ap-
proaches making use of the presumed causal
relationships between, for example, rates of PCr
resynthesis and [ADP]32 are difficult when ADP
changes during exercise are relatively small, as
they tend to be when pH changes are large. We
have chosen an exercise protocol that produces
adequate PCr depletion in subjects without ex-
cessive PCr depletion and ATP loss, and a method of
data analysis that accounts for variable pH
ARTICLE IN PRESS
Table 3 Six minute walk distance and the peak exercise response on the cycle ergometer in the COPD subjects
(n ¼ 10) before and after exercise training (ET)
Pre-ET Post-ET Mean difference (95%CI)
Work
Watts 4675 5374 7 (2 to 12)
% predicted 4175 4874 7 (1 to 12)
VO2
L/min 0.8170.10 0.8570.04 0.04 (0.07 to 0.1)
ml/kg/min 11.270.8 11.970.5 0.7 (0.9 to 2.3)
% predicted 5977 6376 4 (7 to 15)
VCO2 (L/min) 0.8470.1 0.8870.1 0.05 (0.1 to 0.2)
VE (L/min) 3273 3472 2 (3 to 7)
VE/MVV (%) 9879 9476 4 (15 to 7)
Vt (L) 1.0470.1 1.0770.1 0.02 (0.1 to 0.1)
fb (brths/min) 3272 3372 2 (1 to 4)
SpO2 (%) 9172 9272 0.5 (1 to 2)
HR (bpm) 11778 11476 2 (9 to 4)
HR (% pred) 7275 7074 2 (5 to 2)
Dyspnea 771 771 0.1 (2 to 1)
RPE 871 971 0.8 (1 to 3)
6MWD (m) 374717 451713 77 (42 to 112)
Data are given as mean7SEM. VO2 : oxygen consumption; VCO2 : carbon dioxide production; VE: minute ventilation; VE/MVV: ratio
of minute ventilation to maximal voluntary ventilation; Vt: tidal volume; fb: breathing frequency; SpO2: oxygen saturation; HR:
heart rate; RPE: rate of perceived exertion; 6MWD: six minute walk distance.
Significantly different to pre-ET (Po0:05).
Exercise capacity and quadriceps metabolism in COPD 1823changes, and which can be used to quantitate
abnormalities in functional mitochondrial capacity
and changes produced by training.
Prior to exercise training in the COPD subjects,
mitochondrial capacity was reduced compared to
the healthy subjects. Previous studies have indi-
cated similar results with an increased PCr t1/2 in
COPD subjects compared to healthy sub-
jects.15,30,31 However, two of these studies also
noted a greater pH change with exercise in the
COPD subjects30,31 which makes the interpretation
difficult.29 In the present study, we allowed for pH
change in our calculation, and infer a defect in
mitochondrial function similar to that in a recent
study.15 In principle, this could be due to a
reduction in mitochondrial volume, intrinsic mito-
chondrial defect or impaired oxygen supply be-
cause of arterial hypoxaemia or reduced capillary
number. A previous study has shown that leg oxygen
delivery at a given power output was not signifi-
cantly different between COPD subjects and
healthy subjects,33 suggesting that impaired oxy-
gen supply was not a factor. Previous studies of
muscle oxidative enzymes34–36 suggest that at least
part of the functional defect is due to reduced
mitochondrial number, volume or enzyme content.
The underlying aetiology for skeletal muscle
dysfunction in COPD subjects has not been con-
clusively determined. Factors proposed to causeskeletal muscle dysfunction in COPD subjects
include poor nutrition,37 corticosteroid use,38 sys-
temic inflammatory processes,39 hypoxia,40 in-
creased oxidative stress3 and disuse.41 Disuse is
probably one of the primary reasons for the
reduced quadriceps mitochondrial capacity prior
to exercise training in the COPD subjects. When the
disuse process was reversed by exercise training,
quadriceps mitochondrial capacity improved. This
will be discussed in the next section.Changes with exercise training in COPD
From PCr recovery kinetics we infer a 38712%
increase in mitochondrial capacity from exercise
training. Furthermore, quadriceps muscle CSA and
MVC increased significantly (772% and 32711%,
respectively) in the COPD subjects following
exercise training.
One other study has examined the effect of a
continuous exercise training protocol on muscle
metabolism using 31P-MRS in COPD subjects.15 Their
results showed a significant improvement in PCr t1/2
following 8 weeks of leg cycle training achieving
values similar to healthy subjects. In that study,
with small pH changes, this amounts to a 48712%
increase in mitochondrial capacity which is slightly,
but probably not significantly, higher than in the
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Z.J. McKeough et al.1824present work. One of the limitations of the work by
Sala and colleagues15 is that they recruited only
male COPD subjects who had not had an exacerba-
tion in the previous 6 months. This is not reflective
of the usual COPD population attending pulmonary
rehabilitation. Furthermore, the study used a
tightly controlled training program of leg cycle
exercise which differs from the comprehensive
exercise training programs often used. The results
of the current study add to the findings by Sala and
colleagues15 that improvement in quadriceps
mitochondrial capacity is also possible in a com-
prehensive exercise training program for subjects
(male and female) who attend pulmonary
rehabilitation.
Another finding of our study was the significant
improvement in 6MWD and peak work capacity on a
cycle ergometer following training performed
twice weekly. In contrast, Ringbaek et al.42 have
suggested that exercise training twice per week
was not sufficient to show improvements in 6MWD.
However, the description of the training component
used in their study was limited with intensity based
on dyspnea levels and the duration of endurance
training (jogging and stair-climbing) not cited. In
our study, an extensive endurance training compo-
nent was prescribed (30min of walking and
20–30min of cycling by week 8) with intensity
based on the 6min walk test and cycle ergometer
test. The trend towards a significant correlation
between the increase in peak leg work capacity and
the improvement in mitochondrial function pro-
vides some evidence that the improvement in peak
exercise capacity was related to the physiological
changes at the skeletal muscle level after training.
The findings of this study were limited by factors
which warrant some caution in data interpretation.
The small sample size may have limited the ability
to distinguish between the COPD and healthy
subjects particularly in regard to baseline muscle
strength. We recognise that a number of studies
have detected differences in muscle strength and
CSA between healthy and COPD subjects.3,11 How-
ever, our healthy control group was sedentary and
slightly older than subjects in these studies which
may have minimised the differences between the
healthy and COPD subjects in our study. In addition,
as there was no COPD control group, the effect of
exercise training on the muscle changes occurring
in the COPD subjects will need to be confirmed in a
randomised controlled trial.
In conclusion, 16 sessions of exercise training,
performed twice weekly, significantly increased
6MWD and peak leg work capacity in the subjects
with COPD. There was a significant improvement in
[PCr] resynthesis kinetics of the quadriceps musclesuggesting an improvement in the oxidative capa-
city of the muscle. Quadriceps muscle mass and
strength also significantly increased following twice
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